Correlation Between Evolus and Elicio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Evolus and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolus and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evolus Inc and Elicio Therapeutics, you can compare the effects of market volatilities on Evolus and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolus with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolus and Elicio Therapeutics.
Diversification Opportunities for Evolus and Elicio Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Evolus and Elicio is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Evolus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolus Inc are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Evolus i.e., Evolus and Elicio Therapeutics go up and down completely randomly.
Pair Corralation between Evolus and Elicio Therapeutics
Given the investment horizon of 90 days Evolus Inc is expected to generate 1.13 times more return on investment than Elicio Therapeutics. However, Evolus is 1.13 times more volatile than Elicio Therapeutics. It trades about 0.27 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.24 per unit of risk. If you would invest 1,051 in Evolus Inc on November 18, 2024 and sell it today you would earn a total of 423.00 from holding Evolus Inc or generate 40.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evolus Inc vs. Elicio Therapeutics
Performance |
| Timeline |
| Evolus Inc |
| Elicio Therapeutics |
Evolus and Elicio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evolus and Elicio Therapeutics
The main advantage of trading using opposite Evolus and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolus position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.| Evolus vs. Collegium Pharmaceutical | Evolus vs. Phibro Animal Health | Evolus vs. ANI Pharmaceuticals | Evolus vs. Procaps Group SA |
| Elicio Therapeutics vs. Noble plc | Elicio Therapeutics vs. Boston Omaha Corp | Elicio Therapeutics vs. Magnite | Elicio Therapeutics vs. Deluxe |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |